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Towards an antimicrobial 
‘microglove’
Ewoud Reilman1, Joke G. Hagting2, Theo Flipsen2, Herb Ulmer2 & Jan Maarten van Dijl1
A large proportion of hospital-related infections are acquired and spread due to the direct contacts 
between patients and healthcare workers. Accordingly, proper infection prevention measures, and 
especially hand hygiene, are key to limit the spread of infections in nosocomial settings. However, 
healthcare workers frequently experience difficulties in complying strictly to hand disinfection 
protocols. This study was therefore aimed at the development of a hand rub with antimicrobial 
activity that forms a protective film on the hand, a so-called microglove, in order to enhance 
hand hygiene. For this purpose, various co-polymer formulations consisting of different ratios of 
Polyvinylpyrrolidone (PVP) and a branched C20 derivatized maleate (M20) in combination with 
the known biocide benzalkonium chloride (BKC) were tested for their combined film-forming and 
antimicrobial activities. The results of a series of novel contamination and transmission assays show 
that a formulation of 80% PVP and 20% M20 co-polymer with 0.9% BKC fulfils the elementary 
requirements for an antimicrobial microglove.
One of the major concerns for hospitals and other healthcare institutions is the continuous threat of 
infections caused by a wide range of opportunistic microorganisms. Hospitalized patients are especially 
susceptible for infections due to their underlying illnesses that may render them frail and/or immuno-
compromised. Additionally, wounds resulting from trauma or surgical interventions represent a breach 
of the primary skin barrier through which pathogens can readily gain access to normally well-protected 
body sites. Today, the majority of the infections caused by bacteria can still be treated reasonably well 
with antibiotics. However, the growing incidence of infections with antibiotic resistant bacteria makes 
treatment increasingly difficult and very costly1,2. This is underpinned by recent studies showing that 
infections with multi-drug resistant bacteria, such as methicillin resistant Staphylococcus aureus (MRSA), 
lead to increased morbidity, mortality and length of stay in hospitals3,4. Especially hospital-acquired (HA) 
bacterial infections are notorious for their drug resistant phenotypes, which originate from the continu-
ously applied antibiotic pressure in nosocomial settings. Importantly, HA infections are to a large extent 
acquired and spread through direct contacts between patients and healthcare workers5–7. Therefore, a 
major prerequisite for success in the fight against HA infections is the strict implementation of effective 
infection prevention measures8.
One of the most effective precautions to minimize the spread of pathogens in healthcare settings 
is the routine decontamination of the hands of healthcare workers in-between patient contacts7,9. On 
a worldwide scale, it has been estimated that the strict implementation of standard control measures, 
in particular hand hygiene, could save one million lives annually10,11. Importantly, the success of the 
implementation of such control measures relies strongly on the strict adherence of healthcare workers 
to the protocol for hand disinfection between patient contacts. Yet, it has been noted that many health-
care workers experience difficulties in complying strictly to hand disinfection protocols for a range of 
different reasons 12–14. A key problem resides in the fact that effective hand hygiene requires the frequent 
re-application of soaps and alcohol- or chlorhexidine-based disinfectants. This can, on the long term, 
negatively affect the quality of the skin, resulting in skin irritation15. In addition, skin damage due to 
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the use of aggressive hand-washing products makes the skin more prone to colonization by pathogenic 
micro-organisms16.
To circumvent the drawbacks of the repeated use of soaps or other disinfectants, the present study 
was aimed at the development of a new antimicrobial hand coating – a so-called ‘microglove’ - with a 
protective effect that would last in the minute to hour time range. Ideally, the antimicrobial microglove 
should consist of a thin comfortable polymer film that can be applied in the form of a hand rub, and 
that then covers the surface of the hands. Furthermore, to avoid interference with established hygiene 
regimens, the microglove coating should be readily removable by hand washing with regular soap and 
water. We therefore focused the present study on developing a Polyvinylpyrrolidone (PVP)-based hand 
rub, since PVP is a water-soluble excipient that is widely used both in the pharmaceutical industry, the 
food industry (E1201), and in numerous personal care products (17; http://www.fda.gov/default.htm). 
For example, PVP is applied in syrups, soft gelatin capsules, shampoos, toothpastes, hair sprays and 
gels, and in contact lens solutions. Accordingly, PVP is generally considered safe. In addition, its unique 
physical and mechanical properties make PVP an ideal candidate for a polymer-based hand rub. By 
using PVP in combination with a derivatized maleate it is possible to create PVP-based co-polymers, so 
called Aegimers, with different solubility properties18. In the present study, we therefore tested various 
co-polymer formulations consisting of different ratios of PVP and a branched C20 derivatized maleate 
named M20 for their film and texture properties. For proof-of-principle, the polymer formulations were 
combined with the known biocide benzalkonium chloride (BKC). BKC is a quaternary ammonium com-
pound with chemical properties that make it interesting for use as a biocidal, cationic surfactant and 
phase transfer agent19. The antimicrobial activity of quaternary ammonium compounds, such as BKC, is 
primarily caused by their disorganizing effect on the plasma membrane20. As a biocidal, BKC has been 
applied in a large range of cosmetic products, non-alcoholic hand sanitizers, skin antiseptics, wet tow-
els, mouth washes, and ophthalmic preparations, even though it can cause irritations of the skin21. The 
resulting polymer-biocide formulations were analyzed for their antibacterial activity. Using simulated 
contamination and transmission assays, a promising candidate ‘microglove’ formulation was identified, 
which consists of a co-polymer of 80% PVP and 20% M20 supplemented with 0.9% BKC (in short 
PVPM20-80:20-0.9% BKC).
Results
PVPM20 can function as coating-carrier for benzalkonium chloride. An antimicrobial 
microglove should be composed of a thin polymer film that is retained on the surface of the hand for a 
period of time in the minutes to hours range. In this study, such a polymer film was created through a 
co-polymer formulation consisting of PVP and M20 (i.e. PVPM20). In a first approach, PVP and M20 
were used in a 90% to 10% ratio, respectively. Different PVPM20-90:10 formulations that either con-
tained 0.1%, 0.5% or 1.0% BKC, or that lacked BKC, were tested for their antimicrobial activity against S. 
aureus, a major nosocomial pathogen with a high impact on morbidity, mortality and length of hospital 
stay22. To this end, aliquots of an exponentially growing S. aureus HG001 culture in Tryptic Soy Broth 
(TSB) were exposed to the different polymer coatings applied to the bottom of 96-well microtiter plate 
wells. The S. aureus HG001 strain was used for these analyses, because it is a well-characterized strain 
that is frequently used in studies on staphylococcal antibiotic resistance, infection and physiology23–27. 
Coatings with the PVPM20 polymer, but without BKC had no effect on growth of S. aureus HG001 
at 37 °C as the cells that were introduced into the wells with only PVPM20-90:10 showed comparable 
growth rates as cells introduced into the untreated wells (Fig. 1A). This showed that PVPM20 itself has 
no antimicrobial activity. When we supplemented the PVPM20-90:10 with 0.1% BKC, the application 
of 5 μ l of undiluted coating resulted in a complete inhibition of growth. However, when this formula-
tion was diluted 10-fold, neither the 2 μ l nor the 5 μ l coatings were able to inhibit growth (Fig. 1B). By 
increasing the concentration of BKC to 0.5% the growth-inhibiting power of the polymer formulation 
increased considerably. In this case, coatings of 2 μ l and 5 μ l of the 10-fold diluted PVPM20-90:10 with 
0.5% BKC were efficiently preventing growth of S. aureus (Fig. 1C). Growth inhibition was even further 
enhanced by using a PVPM20-90:10 formulation with 1.0% BKC, where even the 5 μ l coating of a 100-
fold diluted formulation was sufficient to stop the growth of S. aureus (Fig. 1D). Interestingly, coatings 
of BKC without the PVPM20 polymer, were slightly more effective in stopping the growth of S. aureus 
HG001 (Fig. 1E–G).
The observation that the PVPM20-90:10 polymer formulation slightly decreased the antibacterial 
effects of BKC suggested that the polymer coating of the microtiter plate inhibited the release of BKC into 
the culture medium. This idea was tested in a disk diffusion assay using Tryptic Soy Agar (TSA) plates 
confluently inoculated with S. aureus HG001. After overnight incubation at 37 °C, the growth inhibition 
zones around the paper disks were examined. Upon comparison of the growth inhibition zones around 
paper disks with PVPM20-90:10 plus BKC or with BKC alone, but both containing BKC at the same 
concentration, it was clearly evident that PVPM20-90:10 indeed inhibited the diffusion of BKC into the 
surrounding agar medium. Already at a BKC concentration of 0.1% the PVPM20-90:10 polymer resulted 
in a substantial reduction of the inhibition zone (Fig. 2). This inhibitory effect of PVPM20-90:10 on BKC 
diffusion became less prominent when higher concentrations of BKC were used. The latter observation 
can be explained by the higher concentration gradient of BKC in the PVPM20 relative to the surrounding 
agar medium, resulting in a faster release of the BKC and effectively more BKC that is available to diffuse 
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from the paper disk into the surrounding agar medium. Alternatively, the PVPM20 coating may become 
saturated with BKC, allowing the BKC that is available in excess to diffuse rapidly from the paper disk 
into the surrounding agar medium. The fact that PVPM20-90:10 can set a limit to the diffusion of BKC 
into the surrounding medium implied that PVPM20 could represent an attractive slow-release carrier for 
antimicrobial compounds, such as BKC. In turn, this made the PVPM20-90:10 formulation with BKC 
an attractive candidate for further proof-of-principle studies on the antibacterial microglove concept.
PVPM20-80:20-0.5% BKC effectively prevents S. aureus transmission. In the initial experi-
ments described above, PVP and M20 were used in a 90% to 10% ratio. Since the PVP:M20 ratio is 
an important parameter for the properties of the co-polymer film that is to represent a microglove, we 
synthesized three formulations with different PVP:M20 ratios, namely 90:10 (PVPM20-90:10), 85:15 
(PVPM20-85:15), and 80:20 (PVPM20-80:20). These co-polymer formulations were tested in combina-
tion with different BKC concentrations in an in-house developed contamination and transmission assay 
of which the different steps are schematically represented in Fig. 3. Briefly, stamps covered with a nitrile 
examination glove were either coated with a co-polymer formulation or they were left untreated. These 
stamps were contaminated by pressing them on a TSA plate inoculated with S. aureus HG001 (Fig. 3C). 
Next the stamp was pressed against a second stamp (Fig. 3D) and the second stamp was then pressed 
against a third stamp (Fig. 3E). All three stamps were subsequently pressed on fresh TSA plates (Fig. 3F), 
which were incubated overnight at 37 °C. This assay demonstrated that using the non-coated control 
stamps, transmission of S. aureus HG001 was detectable from the initially contaminated stamp to both 
Figure 1. Growth of S. aureus HG001 in polymer-coated microtiter plates. Different amounts of 
serially diluted PVPM20-90:10 formulations and unaided BKC solutions were used to coat wells in a 96-
well microtiter plate. These PVPM20-90:10 formulations and unaided BKC solutions contained increasing 
BKC concentrations as indicated. S. aureus HG001 was pre-cultured in 150 μ l TSB using uncoated 96-well 
microtiter plates until early exponential growth after which aliquots of 100 μ l were transferred to the 
polymer-coated wells. This transfer from one plate to another plate results in the observed drop in OD600 at 
the time point indicated by the arrows. Subsequently, growth at 37 °C for 1000 min was monitored by optical 
density readings at 600 nm. Notably, in experiment 1D, the killing efficiency of the undiluted formulation 
is apparently decreased compared to the 10-fold dilution. Although this is suggestive of a decreased killing 
activity, we consider it more likely that this observation relates to the formation of small aggregates by the 
respective polymer formulation, which would result in an increased OD600.
www.nature.com/scientificreports/
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the second and third stamps (Fig. 4). The numbers of transmitted bacteria decreased visibly after each 
transfer. Furthermore, the imprints left by the control stamps on the inoculated bioassay plate that was 
used for stamp contamination showed only the outline of the stamps and, as expected, there was no inhi-
bition of bacterial growth. When stamps were coated with the original PVPM20-90:10 formulation con-
taining 0.1% BKC (Fig. 5A), there was still a considerable amount of bacterial transmission by the three 
stamps. Contamination of the first stamp was slightly reduced compared to the uncoated control stamps. 
The imprint on the bioassay plate showed a small clearing zone, which suggests that part of the polymer 
coating was released upon contact with the agar. This can be explained by the fact that BKC residing in 
the polymer coating will diffuse into the agar, resulting in the clearing zones in which bacterial growth 
is inhibited. Increasing the concentration of BKC to 0.3% (Fig.  5A) prevented transmission to stamps 
no. 2 and no. 3, and even stamp no. 1 did not transmit viable bacteria, suggesting that the antibacterial 
coating was successfully applied. However, the imprint on the bioassay plate was characterized by a large 
clearing zone (Fig. 5A). This is likely due to the diffusion of BKC, which implies the release of some of the 
polymer film applied to the stamp. Increasing the BKC concentration to 0.5%, 1%, 2% and 5% resulted in 
even larger clearing zones (Fig. 5A). This can be explained as a direct consequence of increasing the BKC 
concentration. However, this can, at least in part, also be attributed to a secondary effect of the increasing 
BKC concentrations, since BKC is a well-known surfactant and phase-transfer catalyst that may change 
the water-resistant properties of the polymer film. Upon changing the PVP and M20 ratio to 85% and 
15%, respectively (i.e. PVPM20-85:15), the addition of 0.1% BKC did not prevent the contamination of 
stamps no. 2 and no. 3 (Fig. 5B). Increasing the BKC concentration to 0.3%, which proved to be effec-
tive when using the PVPM20-90:10 formulation, was also not sufficient to fully prevent transmission to 
stamp no. 3. Nevertheless, the number of transmitted bacteria was clearly reduced. This was most likely 
due to some release of the polymer film, as was also reflected by the large clearing zone on the inoculated 
bioassay plate (Fig. 5B). Applying PVPM20-85:15 with a BKC concentration of 0.5% prevented bacterial 
transmission to stamp no. 2 and no. 3, but could not prevent contamination of the stamp no. 1. When 
the BKC concentration was increased to 1% and higher, none of the stamps showed contamination. 
However, the large clearing zones on the inoculated bioassay plate were indicative for the release of the 
polymer film obtained when PVP and M20 were present at a ratio of 80% and 20%, respectively (i.e. 
PVPM20-80:20). In combination with 0.1% BKC, the PVPM20-80:20 was still not sufficient in preventing 
transmission to stamp no. 3, However, the coating of the stamps with PVPM20-80:20 containing 0.3% 
BKC resulted in a substantial reduction of S. aureus HG001 transmission, although it was not completely 
prevented. Importantly, in this case, no clearing zones were detectable on the inoculated bioassay plate 
used to start the transmission experiment (Fig.  5C). Increasing the BKC concentration to 0.5% com-
pletely abolished the contamination of all three stamps, again without generating a clearing zone on 
the inoculated bioassay plate (Fig.  5C). This indicates that while the polymer film remained intact on 
the stamp it was able to prevent stamp contamination with bacteria and their subsequent transmission. 
PVPM20-80:20 co-polymer films containing BKC concentrations of 1% or more released substantial 
amounts of BKC onto the inoculated bioassay plate, as reflected by large clearing zones (Fig. 5C). Based 
Figure 2. BKC disk diffusion assay in the presence or absence of PVPM20-90:10. TSA plates were 
inoculated confluently with S. aureus HG001. Next, Whatman paper disks loaded with BKC at different 
concentrations (0.1%, 0.5% or 1%) either with or without PVPM20-90:10 were placed on top of the plates. 
After overnight incubation at 37 °C growth inhibition zones were detectable around the paper disks. The 
circles underneath the images of the plates represent the respective sizes of the inhibition zones when disks 
were loaded with BKC alone (red) or with BKC plus PVPM20-90:10 (green); the red circle underneath the 
first plate (no BKC) indicates the size of the paper disk.
www.nature.com/scientificreports/
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on the significant antibacterial activity of the PVPM20-80:20 supplemented with 0.5% BKC, and on the 
stable film that it forms, the PVPM20-80:20 formulation was selected for further testing.
PVPM20-80:20 coating facilitates slow BKC release. The slow BKC release properties of the 
PVPM20-80:20 co-polymer formulation were verified in a BKC release test that was performed in a 
96-well plate. In this experiment the PVPM20-90:10, PVPM20-80:20 and PVPM20-75:25 formulations 
were supplemented with 0.9% BKC and coated to the first well of each row of a 96-well plate. After 
evaporation of the 2-propanol solvent, an aqueous bromophenol blue (BPB) solution was added to the 
coated wells and the plate was incubated for 1 min at room temperature. BPB forms a blue complex 
with free BKC when it is released from the polymer film into aqueous solution. Of note, the BPB-BKC 
complex is blue, whereas the BPB solution itself is purple28. After incubation, the solution was transferred 
to the second well, and the color shift was assessed visually. Subsequently, new BPB solution was added 
to the polymer-BKC-coated wells, and incubated for 1 min and transferred to the third well. This course 
of actions was repeated until blue BPB-BKC complexes were no longer observed. The number of cycles 
needed to release readily detectable amounts of BKC was used as a measure to assess the BKC-retaining 
properties of the different polymer formulations. The results of this test showed that the PVPM20-80:20 
formulation was most efficient in releasing BKC from the film (Fig.  6), as it took up to 8 consecutive 
Figure 3. Design of a contamination and transmission assay. (A) Stamp design; stamps were made of 
screw caps for laboratory flasks on top of which absorption paper was fixed with parafilm. (B) Example 
of one of the three stamps wrapped with a nitrile examination glove. (C) Contamination procedure; a 
first stamp (no. 1) was pressed for 10 sec onto a TSA plate inoculated with S. aureus HG001. (D) First 
transmission step; stamp no. 1 was pressed to stamp no. 2 for 5 sec. (E) Second transmission step; stamp no. 
2 was pressed to stamp no. 3 for 5 sec. (F) Contamination of stamps with S. aureus HG001 was assessed by 
pressing the stamps onto TSA plates.
www.nature.com/scientificreports/
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incubations with the aqueous BPB solution until BKC was no longer detectably released (Fig.  6). In 
contrast, the film made with the PVPM20-75:25 formulation showed BKC release for only 2 incuba-
tions, after which the film completely disintegrated. The PVPM20-90:10 formulation performed slightly 
better, but after 5 consecutive incubations with the BPB solution no detectable amounts of BKC were 
released from the film. These findings were consistent with the results shown in Fig. 5, which indicated 
that the PVPM20-80:20 formulation was the most suitable candidate formulation for further testing. 
Additionally, we tested the BKC release from a 0.9% BKC coating without PVPM20-80:20. In this case, 
all coated material dissolved instantaneously upon addition of the BPB solution and all BKC was thereby 
released. Of note, the BKC concentration in commercially available formulations is lower (~0.2%) than 
the concentration used in our present polymer formulations. However, the BKC-release assay shows that 
by using BKC in combination with the PVPM20-80:20 polymer, the actual release of free BKC from the 
polymer film is considerably lower than that of unaided BKC as implemented in commercial BKC-based 
disinfectants. Combined with the other data presented above, it can thus be concluded that the high 
concentration of BKC is retained within the PVPM20-80:20 polymer film and is only slowly released 
upon contact with water. This slow BKC release combined with the good film properties implied that 
the PVPM20-80:20 0.9%BKC formulation matched the basic requirements for a hand rub that facilitates 
the establishment of an antibacterial microglove.
Validation of the antibacterial microglove concept. To test whether the PVPM20-80:20 0.9%BKC 
formulation could function as a microglove that offers protection against microbial contamination, its 
functionality was evaluated using a glove contamination assay. In this assay 13 volunteers were asked to 
wear a PVPM20-80:20 0.9%BKC-treated and an untreated examination glove (control), while performing 
their normal daily activities with the exception of hand washing and disinfection. After approximately 
3 hours, both gloved hands were pressed gently on a Lysogeny Broth (LB) agar plate to assess the lev-
els of microbial glove contamination. The plates were incubated overnight at 37 °C, and the next day 
the colony-forming units (CFUs) on the plates (Fig. 7A) were counted. Indeed, the gloves coated with 
the PVPM20-80:20 0.9%BKC formulation yielded significantly lower numbers of CFUs on the inner 
hand surface than the non-coated gloves, demonstrating a protective antimicrobial effect of the polymer 
coating (Fig.  7B). Overall, the numbers of CFUs were approximately halved when a glove was treated 
with PVPM20-80:20 0.9%BKC, but in some individual experiments the effect was substantially more 
prominent with up to 40-fold reductions in CFUs. For unknown reasons, other experiments showed less 
pronounced antimicrobial effects of the polymer coating. Even so, in each single experiment the coating 
Figure 4. Controls for the contamination and transmission assay. The first three columns depict the 
contamination of the three stamps with S. aureus HG001 as reflected by colony formation on the fresh TSA 
plates onto which the non-polymer-coated stamps were pressed. The last column shows the imprint that was 
left on the ‘contamination plate’ (inoculated with S. aureus HG001) after overnight incubation.
www.nature.com/scientificreports/
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of a glove with PVPM20-80:20 0.9%BKC led to a reduced number of microbial contaminants compared 
to the respective control (Fig.  7B). This shows that the microglove concept has indeed a considerable 
protective effect against newly acquired contaminants for a period of approximately 3 hours.
Figure 5. Effects of polymer coating on contamination and transmission. Stamps were coated with (A) 
PVPM20-90:10, (B) PVPM20-85:15, or (C) PVPM20-80:20 supplemented with different concentrations of 
BKC as indicated. The first 3 columns depict the contamination of the three stamps with S. aureus HG001 
as reflected by colony formation on the fresh TSA plates onto which the stamps were pressed. The last 
column shows the imprint that was left on the contamination plate (inoculated with S. aureus HG001) after 
overnight incubation.
Figure 6. Release of BKC from different polymer formulations. Picture of the 96-well microtiter plate 
assay where the first well (marked ‘coated’) was used for the polymer coating and subsequent incubation 
steps with bromophenol blue (BPB) solution. Wells 1-10 contain the BPB solutions after incubation with 
the coating in the first well. The applied polymer formulations and the respective BKC concentrations are 
indicated. Of note, for unknown reasons, the BKC batch used for this experiment and the experiments in 
Fig. 7 had a slightly lower bactericidal activity than the batch used for the experiments shown in Figs 1–5. 
Therefore, the BKC concentration was increased to 0.9%. Furthermore, in case of the PVPM20-75:25 
formulation, the structure of the film is compromised by the addition of water. As a result, small pieces of 
film are transferred to the other wells, which is clearly visible in well numbers 1, 2, 4, 5 and 6. These pieces 
of film still release some BKC.
www.nature.com/scientificreports/
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Discussion
In this study, we provide the proof-of-principle for a new type of antimicrobial hand rub that forms a 
protective microglove and has the potential to be used as an alternative for the current disinfectants 
applied by healthcare workers. The great advantage of the antimicrobial microglove concept is that it 
reduces the risks of microbial hand contamination for healthcare workers and, consequently, the risks 
of transmission of pathogens from healthcare workers to patients for a period of time that is sufficiently 
long for patient examination and the provision of care. Due to its antimicrobial activity, the microglove 
may reduce the critical need for repetitive hand disinfection procedures. Importantly, since in principle 
fewer hand disinfection events are needed for protection, the microglove could potentially enhance the 
compliance of healthcare workers with established hygiene protocols.
The present microglove formulation is based on a co-polymer of PVP and the branched C20 derivat-
ized maleate M20. This co-polymer is dissolved at a concentration of 5% in 2-propanol and is supple-
mented with 0.9% BKC. Like in commercially available alcohol-based disinfectants, such as Sterillium®, 
the initial disinfection is most likely caused by the solvent 2-propanol. However, after the 2-propanol 
evaporates, a thin polymer film containing the active biocide BKC remains on the skin forming the 
protective microglove. Of note, there are other BKC-based disinfectants currently on the market, but 
these do not claim to protect users against renewed microbial contamination after they have disinfected 
their hands.
Most of the currently commercially available BKC-based products contain about 0.2% BKC, while the 
present microglove formulation contains 0.9% BKC. Importantly, our present findings indicate that not 
all of this BKC is instantaneously released from the co-polymer film. Instead, the BKC is retained by the 
polymers and slowly released into the environment. We consider this as an advantageous property to 
protect hands against microbial contamination, and also to limit the subsequent transmission of micro-
bial contaminants. Furthermore, the fact that most of the BKC in the microglove formulation remains 
confined in the polymer film, and is not immediately released, is likely to limit the actual hand exposure 
to BKC, thereby minimizing a possible irritation of the skin by BKC.
Figure 7. Effects of polymer coating on microbial glove contamination. (A) Example plate depicting the 
contamination of polymer-coated and non-coated examination gloves. The gloves were worn by a volunteer 
for 3 hours during which time the volunteer performed regular activities. Subsequently, the volunteer gently 
pressed the gloves onto a bioassay plate with LB agar. The picture was taken with the Syngene G:box after 
overnight incubation at 37 °C. In this example, the left glove was used as an uncoated control, while the 
right glove was coated with PVPM20-80:20 0.9% BKC. (B) Results of the glove contamination assays. Coated 
and non-coated gloves were worn by 13 volunteers for about 3 hours. Colony forming units on the LB plates 
onto which the used gloves were pressed, were counted with the Syngene software. The outcome of each 
individual experiment is indicated with a different color code, allowing the comparison of the contamination 
of each pair of coated and non-coated gloves. The uncertainty in counting was marginal as this was done 
automatically, giving always the same outcome as long as the camera settings were not altered. In this 
respect it is relevant to note that the CFU’s obtained for the control gloves were always determined at the 
same time as the CFU’s obtained from the coated gloves. Statistical analyses were done using the Mann–
Whitney U test. Horizontal black bars indicate average numbers of colony forming units.
www.nature.com/scientificreports/
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In our present study, optimal BKC release was observed for the PVPM20-80:20 co-polymer formu-
lation. The rate of BKC release is mainly determined by the hydrophilicity of the co-polymer film. The 
hydrophilicity determines the degree of swelling in aqueous media and, with that, the permeability for 
the water-soluble BKC. In this respect, the PVPM20-90:10 co-polymer film is more hydrophilic and 
takes up more water resulting in faster release of BKC compared to the PVPM20-80:20 co-polymer film. 
The film of PVPM20-80:20 and the film of PVPM20-90:10 adhere both strongly to the bottom of the 
surface-modified polar polystyrene well. The less hydrophilic and thus more apolar film of PVPM20-
75:25 adheres less effectively to the bottom of the well. Consequently, during transfer of the BPB medium, 
pieces of the PVPM20-75:25 film are transferred to the second well, which disturbs the imaging. In other 
words, the BKC release from coated films also depends on adhesion phenomena.
In conclusion, the present study demonstrates the feasibility of a disinfecting hand sanitizer that 
can be regarded as an antimicrobial microglove. The microglove formulation that was tested provided 
increased protection against newly acquired microbial contaminants for a period of at least three hours. 
Although our microglove concept is technically feasible, it is key to realize that this type of product 
cannot replace strict hygiene protocols. Instead, it should be regarded as a tool that is complementary 
to existing hygiene protocols, and that can potentially enhance the efficacy of such protocols. Lastly, it 
should be noted that further optimization studies will be needed before an antimicrobial microglove can 
be implemented in the daily routine. In the first place, it would be important to further increase the bac-
tericidal activity of the microglove to enhance the protective effect. Furthermore, the current microglove 
formulation and/or the amounts of polymer applied convey a certain stickiness that could be perceived 
as unpleasant. However, a great advantage of the PVPM20 co-polymer system is that its chemical and 
physical properties can be easily modified and this, in combination with optimization of the hand rub 
formulation, provides ample possibilities for further development towards a novel solution in reducing 
hospital-acquired infections.
Methods
Strains and growth media. S. aureus HG00123 was grown in TSB or on TSA. Liquid S. aureus 
HG001 cultures were grown in 96-well plates at 37 °C and under constant agitation using a Biotek pow-
erwave microplate reader.
Co-polymers. Co-polymers with different ratios of PVP and M20 were prepared by PolyVation 
BV. These different co-polymers (in short PVPM20) were dissolved to a final concentration of 5% in 
2-propanol. The resulting PVPM20 solutions were then supplemented with different concentrations of 
BKC (Sigma Aldrich).
Co-polymer screening for antimicrobial activity. The co-polymer antimicrobial activity screen 
was performed with PVP and M20, mixed at a 90% to 10% ratio, respectively, and supplemented with 
0.1%, 0.5% or 1.0% BKC from a 50% (w/v) stock solution. PVPM20-90:10 without BKC, and BKC solu-
tions of 0.1%, 0.5% or 1.0% without PVPM20 were used as controls. The different formulations were 
used to coat 96-well microtiter plates by applying different aliquots to the bottoms of the wells; 5 μ l of 
the original 5% PVPM20 solutions, 2 μ l and 5 μ l of 0.5% PVPM20 solutions (10x diluted), and 2 μ l and 
5 μ l of 0.05% PVPM20 solutions (100x diluted). The wells were air-dried, resulting in the deposition of a 
polymer film on the bottom of the wells. The BKC controls were applied using the same approach. Next, 
100 μ l aliquots of a culture of exponentially growing S. aureus HG001 in TSB were added to the wells 
and growth was monitored for 14 hours by optical density readings at 600 nm (OD600) using a Biotek 
powerwave plate reader at maximal shaking.
Disk diffusion assay. PVPM20-90:10 (5%) formulations with either 0.1%, 0.5% or 1% BKC were 
spotted in 5 μ l aliquots on 5 mm Whatman® paper disks. Alternatively, 5 μ l aliquots of 0.1%, 0.5% or 1% 
BKC solutions were spotted on the disks. After disk drying at room temperature, the disks were placed 
on TSA plates onto which S. aureus HG001 had been spread to obtain a confluent lawn of cells. These 
plates were then incubated overnight at 37 °C and, the next day, the sizes of the observed inhibition zones 
were measured to estimate the diffusion of BKC from the paper disks
S. aureus contamination and transmission assay. To assay the impact of different polymer for-
mulations on the contamination of surfaces with S. aureus and the subsequent S. aureus transmission 
to other surfaces, a dedicated assay was developed. Briefly, an overnight culture of S. aureus HG001 
was diluted 1:10.000 and 1 ml was plated confluently onto two large bioassay plates with TSA. After 
inoculation, the plates were dried at 37 °C for approximately 30 min to allow bacteria to settle and to 
remove access moisture. Nitrile examination gloves were wrapped around self-fabricated stamps (Fig. 3, 
A and B), which were made from absorption towel placed on a bottle cap and secured by a parafilm 
wrapping (Fig. 3A). The gloved stamps were coated with 50 μ l polymer formulations, or they were left 
untreated (control). Contamination and transmission was achieved by pressing the gloved stamp (no. 
1) onto the plate inoculated with S. aureus for approximately 10 sec (Fig. 3C). The stamp was then used 
to contaminate a second stamp (no. 2) by pressing the two together for 5 sec (Fig.  3D), after which it 
was pressed for 5 sec onto a clean TSA plate (Fig. 3F). Subsequently, the second stamp was first pressed 
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against a third stamp (no. 3; Fig. 3E), and both stamps were then pressed onto clean TSA plates for 5 sec 
(Fig.  3F). All plates were incubated overnight at 37 °C. Bacterial growth on the agar plates, including 
that on the two bio-assay plates used for the initial contamination of stamp no. 1, was used to assess the 
quality and anti-bacterial capacity of the polymer films applied to the stamps. Importantly, we included 
five non-coated control stamps, which were pressed onto different locations on the bioassay plates, to 
preclude a possible position-related assay bias.
BKC release assay. The different polymer formulations (i.e. PVPM20-90:10, PVPM20-80:20, and 
PVPM20-75:25 in 2-propanol) were supplemented with 0.9% BKC and 20 μ l coated to the first well 
of each row of a 96-well plate. After evaporation of the 2-propanol solvent, 100 μ l of an aqueous BPB 
solution (6 × 10−4 mmol/L) was added to the coated wells and the plate was incubated for 1 min at room 
temperature. Next, the aqueous phase was removed from the well and the formation of blue BPB-BKC 
complexes was assessed by visual inspection. This process was repeated until blue BPB-BKC complexes 
were no longer observed, and the number of repeated BPB incubation steps was recorded.
Glove contamination assay. Nitrile examination gloves (Sterling Nitrile Powder-Free Exam Gloves, 
Kimberly-Clark) were coated with 1 ml of PVPM20-80:20 (5%) dissolved in 2-propanol and supple-
mented with 0.9% BKC. As a control, untreated nitrile examination gloves were used. Next, 13 volunteers 
were asked to wear a PVPM20-80:20 0.9%BKC-treated and an untreated examination glove (control), 
while performing their normal daily activities. To prevent a dominant hand bias, the coated glove was 
randomly assigned to the left or right hands of the volunteers. After ~3 hours, both gloved hands were 
pressed gently on a LB agar plate which was then incubated overnight at 37 °C. Images were recorded 
with a G:BOX gel documentation and analysis system (Syngene). The numbers of CFUs on the plate were 
automatically assigned using the Syngene software package. CFU numbers thus determined were used as 
a measure for the numbers of microbial contaminants that had adhered to the glove.
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